Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
CytoSorbents Q1 2026 Misses Forecasts, Stock FallsKing of Eswatini visits ASAN serviceHaber Global's WUF13 report: Azerbaijan's construction experienceIntl Conference at MDU: Scholars from 23 CountriesNew Appointment at Azerbaijani Embassy in UK: Rashad KhanlarovCar imports from Georgia to Azerbaijan in 2024Mizuho Raises STM Price Target on AI GrowthHongkong Land Recycles $600M Capital in Q1Tourism Faculty Building Renovation for $4.5MWhy is ISS stock surging?CytoSorbents Q1 2026 Misses Forecasts, Stock FallsKing of Eswatini visits ASAN serviceHaber Global's WUF13 report: Azerbaijan's construction experienceIntl Conference at MDU: Scholars from 23 CountriesNew Appointment at Azerbaijani Embassy in UK: Rashad KhanlarovCar imports from Georgia to Azerbaijan in 2024Mizuho Raises STM Price Target on AI GrowthHongkong Land Recycles $600M Capital in Q1Tourism Faculty Building Renovation for $4.5MWhy is ISS stock surging?
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#cytomx-therapeutics

Latest news and interesting information about cytomx-therapeutics.

Wolfe Research Initiates CytomX Stock with Outperform
Today / 10:31
|
290

Wolfe Research Initiates CytomX Stock with Outperform

Wolfe Research initiated CytomX Therapeutics (CTMX) with an outperform rating and $3.50 target. Varseta-M shows promise in colorectal cancer.

ANALYST RATINGS →
0
...